In T2D, this leads to reduced LPL activity and ensuing lipotoxicity, characterized by increased deposition of lipids within tissues, including cardiac tissue, further enhancing insulin resistance and promoting CVD. This evidence concerns the gene LPL and type 2 diabetes mellitus.